[1]薛卫成,樊祥山,孟刚整理.胃癌相关标志物免疫组化指标选择专家共识(2014)[J].临床与实验病理学杂志,2014,(09):951-953.
点击复制

胃癌相关标志物免疫组化指标选择专家共识(2014)

参考文献/References:

[1]《胃癌HER2检测指南》编写组. 胃癌HER2检测指南[J]. 中华病理学杂志,2011, 40(8): 553-7.
[2]Derde L P, Cooper B S, Goossens H, et al. Interventions to reduce colonisation and transmission of antimicrobialresistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial[J]. Lancet Infect Dis, 2014, 14(1): 31-9.
[3]Lee J, Ou S H. Towards the goal of personalized medicine in gastric cancertime to move beyond HER2 inhibition[J]. Discov Med, 2013, 16(86): 7-14.
[4]Lee J, Ou S H. Towards the goal of personalized medicine in gastric cancertime to move beyond HER2 inhibition[J]. Discov Med, 2013, 15(85): 333-41.
[5]Kim M A, Lee H S, Lee H E, et al. EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number[J]. Histopathology, 2008, 52(6): 738-46.
[6]Ha S Y, Lee J, Kang S Y, et al. MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas[J]. Mod Pathol, 2013, 26(12): 1632-41.
[7]Catenacci D V, Henderson L, Xiao S Y, et al. Durable complete response of metastatic gastric cancer with antiMet therapy followed by resistance at recurrence[J]. Cancer Discov, 2011, 1(7): 573-9.
[8]Hwang J E, Hong J Y, Kim K, et al. Class III betatubulin is a predictive marker for taxanebased chemotherapy in recurrent and metastatic gastric cancer[J]. BMC Cancer, 2013, 13:431.
[9]Gao J, Lu M, Yu J W, et al. Thymidine Phosphorylase/betatubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving firstline capecitabine plus paclitaxel[J]. BMC Cancer, 2011, 11:177.
[10]De Dosso S, Zanellato E, Nucifora M, et al. ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatinbased chemotherapy[J]. Cancer Chemother Pharmacol, 2013, 72(1): 159-65.
[11]Ichikawa W, Takahashi T, Suto K, et al. Simple combinations of 5FU pathway genes predict the outcome of metastatic gastric cancer patients treated by S1[J]. Int J Cancer, 2006, 119(8):1927-33.
[12]Hashimoto K, Aoyagi K, Isobe T, et al. Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer[J]. Gastric Cancer, 2014, 17(1): 97-106.
[13]Zhou Y N, Xu C P, Han B, et al. Expression of Ecadherin and betacatenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival[J]. World J Gastroenterol, 2002, 8(6): 987-93.

相似文献/References:

[1]朱 萌,张 宁,李 潇,等.外泌体介导miR-106a转运对胃癌细胞腹膜种植转移的影响[J].临床与实验病理学杂志,2019,(06):631.[doi:10.13315/j.cnki.cjcep.2019.06.001]
 ZHU Meng,ZHANG Ning,LI Xiao,et al.Effect of exosomes-mediated transfer of miR-106a on the peritoneal implantation of gastric cancer cells[J].Chinese Journal of Clinical and Experimental Patholog,2019,(09):631.[doi:10.13315/j.cnki.cjcep.2019.06.001]
[2]王岳君,王娜娜,杨苗苗,等.胃癌中PD-L1蛋白表达及分布特征的病理学意义[J].临床与实验病理学杂志,2019,(09):1053.[doi:10.13315/j.cnki.cjcep.2019.09.010]
 WANG Yue-jun,WANG Na-na,YANG Miao-miao,et al.Pathological study on expression and distribution of PD-L1 protein in gastric cancer[J].Chinese Journal of Clinical and Experimental Patholog,2019,(09):1053.[doi:10.13315/j.cnki.cjcep.2019.09.010]
[3]程志芬,孙凤丹,张金子,等.胃癌组织中TGFβ1、TGFβRⅡ、Smad2/3和CDC25蛋白的表达及其临床意义[J].临床与实验病理学杂志,2011,(10):1044.
 CHENG Zhi fen,SUN Feng dan,ZHANG Jin zi,et al.Expressions and clinical significance of TGFβ1,TGFβRⅡ,Smad2/3 and CDC25 in gasrtic carcinoma[J].Chinese Journal of Clinical and Experimental Patholog,2011,(09):1044.
[4]刘江惠,姜忠彩,郭建文,等.胃癌中Ecadherin、MMP2的表达及侵袭转移机制[J].临床与实验病理学杂志,2011,(03):243.
 LIU Jiang hui,JIANG Zhong cai,GUO Jian wen,et al.Expression of Ecadherin and MMP2 in gastric carcinoma and its mechanism of invasion and metastasis[J].Chinese Journal of Clinical and Experimental Patholog,2011,(09):243.
[5]廖谦和,吴文珍,夏康,等.胃癌及癌旁黏膜组织中CK7、CK20和Ki67表达的临床意义[J].临床与实验病理学杂志,2011,(03):313.
[6]姚青,王焱,刘彬彬,等.透明细胞软骨肉瘤1例报道及文献复习[J].临床与实验病理学杂志,2009,(04):26.
[7]贺菊香,赵久达,李文梅,等.Snai2在人胃癌细胞系中的差异表达及生物学意义[J].临床与实验病理学杂志,2008,(06):706.
 HE Ju xiang,ZHAO Jiu da,LI Wen mei,et al.Differential expression of Snai2 in human gastric cancer cell lines and its biological significance[J].Chinese Journal of Clinical and Experimental Patholog,2008,(09):706.
[8]梁雅静,郝金成.胃淋巴上皮瘤样癌1例并文献复习[J].临床与实验病理学杂志,2011,(02):196.
[9]潘玉林,谢蕴,罗志谋.胃钙化性纤维性肿瘤1例[J].临床与实验病理学杂志,2011,(02):220.
[10]黄文斌,朱晓群,黄悦,等.前列腺特异性膜抗原在胃癌组织新生血管中的表达及意义[J].临床与实验病理学杂志,2010,(05):581.
 HUANG Wen bin,ZHU Xiao qun,HUANG Yue,et al.Expression of prostatespecific membrane antigen and its role in tumorassociated neovasculature of gastric carcinoma[J].Chinese Journal of Clinical and Experimental Patholog,2010,(09):581.

更新日期/Last Update: 2014-09-30
版权所有© 2010  临床与实验病理学杂志
地址:合肥市梅山路81号安徽医科大学内     电话:0551-65161102
皖ICP备11021972号-2